scispace - formally typeset
N

Nikolaos K. Robakis

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  124
Citations -  9280

Nikolaos K. Robakis is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Amyloid precursor protein & Presenilin. The author has an hindex of 53, co-authored 120 publications receiving 8953 citations. Previous affiliations of Nikolaos K. Robakis include Mount Sinai Hospital & New York State Office for People With Developmental Disabilities.

Papers
More filters
Journal ArticleDOI

A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions

TL;DR: It is shown that presenilin‐1 (PS1), a protein involved in Alzheimer's disease, controls a γ‐secretase‐like cleavage of E‐cadherin that stimulates disassembly of the E‐ cadher in– catenin complex and increases the cytosolic pool of β‐catenin, a key regulator of the Wnt signaling pathway.
Journal ArticleDOI

Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.

TL;DR: Localization of the corresponding genomic sequences on human chromosome 21 suggests a genetic relationship between Alzheimer disease and Down syndrome, and it may explain the early appearance of large numbers of neuritic plaques in adult Down syndrome patients.
Journal ArticleDOI

A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-Cadherin Is Inhibited by PS1 FAD Mutations

TL;DR: It is shown that a PS1-dependent gamma-secretase protease activity promotes an epsilon-like cleavage of N-cadherin to produce its intracellular domain peptide, N-Cad/CTF2, which functions as a potent repressor of CBP/CREB-mediated transcription.
Journal Article

Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

TL;DR: The hypothesis that oxidative stress may be involved in the pathogenesis of Alzheimer's disease is supported.
Journal ArticleDOI

PS1 activates PI3K thus inhibiting GSK‐3 activity and tau overphosphorylation: effects of FAD mutations

TL;DR: It is shown that PS1, a protein involved in familial Alzheimer's disease (FAD), promotes cell survival by activating the PI3K/Akt cell survival signaling, and this function of PS1 is unaffected by γ‐secretase inhibitors.